Question 1 · Easy
A 29-year-old man is diagnosed with HIV-1 at an ICTC. He has no opportunistic infection, CD4 count is 480 cells/µL and renal function is normal. Under NACO guidelines, which first-line ART should he start?
- ANo ART until the CD4 count falls below 350
- BZidovudine + lamivudine + nevirapine
- CTenofovir + lamivudine + dolutegravir
- DTenofovir + lamivudine + efavirenz
Show answerHide answer
Answer: C · Tenofovir + lamivudine + dolutegravir
India follows 'treat all': ART is offered to every person with HIV regardless of CD4 count, ideally within days of diagnosis. The preferred first-line regimen for adults is the single-pill combination TLD (tenofovir, lamivudine and dolutegravir), which is potent, well tolerated and has a high barrier to resistance. Early ART cuts illness and death, and an undetectable viral load stops sexual transmission.
- A: CD4-based thresholds were dropped when India adopted treat-all.
- B: Zidovudine and nevirapine are older drugs with more toxicity and are not preferred.
- D: Efavirenz-based TLE was the earlier first-line regimen, now replaced by TLD.